Women's Health Updates — May 2023
Learn about recent developments in women's health as well as SWHR's activities that promote the study of sex and gender influences on health and serve our mission to improve women's health through science, policy, and education.
|
|
SWHR HOSTS ANNUAL AWARDS GALA |
|
Thank you to all who joined us in-person for the Annual Awards Gala on Wednesday, April 26, 2023, honoring three leaders who have advanced women’s health: Dr. Kaveeta Vasisht (FDA), Horizon Therapeutics, and Dr. Pauline Maki (University of Illinois Chicago).
|
|
Honorees and Presenters from the 2023 Annual Awards Gala |
|
Katie Schubert, MPP, CAE (left). Gretta Stone (middle), Julie Louise Gerberding, MD, MPH (right)
|
|
Meghan Feely, MD, FAAD (left), Kaveeta Vasisht, MD, PharmD (right) |
|
Gretta Stone (left), Keli Walbert (right) |
|
Sudip S. Parikh, PhD (left), Pauline M. Maki, PhD, (right) |
|
|
SWHR HOSTS WOMEN'S ALZHEIMER'S LUNCHEON |
|
WOMEN'S HEALTH MONTH
May is an important time to promote women's wellness across the lifespan; support women in their roles as patients, providers, and caregivers; and advance women's health research with greater funding and focus. How are you celebrating Women's Health Month? Share with SWHR by responding to this email!
|
|
LUPUS AWARENESS MONTH
Lupus is a chronic condition with no cure, impacting more than 1.5 million Americans. This May, learn to support lupus patients' wellness. Check out the SWHR Living Well With Lupus Toolkit!
|
|
OLDER AMERICANS MONTH
As the U.S. population ages, the burden of health conditions like Alzheimer's disease and bone fractures are expected to rise. But healthy aging is within reach! This month, check out SWHR's many older adult resources, like the Bone Health Policy Call to Action.
|
|
HEALTHY VISION MONTH
The 2023 theme for Healthy Vision Month is "A Family Focus," encouraging families to learn how to protect their vision together. Read more about the importance of eye health across the lifespan in SWHR's Eye Health Toolkit and check out more resources from the National Eye Institute.
|
|
PSORIATIC ARTHRITIS AWARENESS MONTH
Arthritis and psoriatic arthritis (PsA) can develop at any age and cause inflammation, stiffness, and pain in the joints. May is both PsA Awareness Month and Arthritis Awareness Month, bringing needed attention to these conditions. Read the SWHR Psoriatic Arthritis Toolkit for more.
|
|
SWHR is partnering with the Partnership for Women's Health Research (PWHR Canada) to kick off the Annual Meeting of the Organization for the Study of Sex Differences (OSSD) on Sunday, May 7, 2023 in Calgary, Canada.
|
|
MAY 8: NATIONAL WOMEN'S CHECKUP DAY
For National Women's Checkup Day, remember regular doctors visits, screenings, and checkups for you and your family are essential for lifelong wellness. Schedule a checkup today!
|
|
SWHR will present its Biology of Sex Differences article, “The roles of sex and gender in women’s eye health disparities in the United States” on May 10, during the OSSD Annual Meeting. The conversation will be led by Irene O. Aninye, PhD, SWHR Chief Science Officer.
|
|
The 7th Annual Vivian W. Pinn Symposium honors the first full-time director of the NIH Office of Research on Women's Health, Dr. Vivian Pinn, and is held during National Women’s Health Week. This year’s symposium is titled “Menopause and Optimizing Midlife Health of Women.”
|
|
Join SWHR for an "Emerging Topics in Women’s Health" pre-conference symposium on Thursday, May 18, 2023, focused on uterine health. The event is free and requires separate registration from the VCU Health of Women conference.
|
|
|
During this special web event on Monday, June 5, 2023, 1:30 p.m. ET, SWHR will bring together representatives from academic journals for a conversation about elevating the importance of sex differences research in academic publishing.
|
|
|
|
SWHR is always seeking stories about diagnoses, seeking or providing care, and living with lupus, menopause, autoimmune disease, HPV-associated cancer, heart disease, lung cancer, or other conditions or life stages. Visit swhr.org/shareyourstory or click the button above to learn more.
|
|
SWHR Adds Lupus to the Women's Health Equity Initiative
The Initiative includes conditions that pose a disproportionate impact on women’s health based on race and ethnicity, geography, age, and role as a caregiver, such as Alzheimer's disease, bone health, lupus, maternal health, and menopause.
|
|
Ninety percent of lupus patients are women, and lupus is two to three times more prevalent among African American, Hispanic and Latina, Asian American, Native American, Alaska Native, Native Hawaiian and other Pacific Islander women. Check out the new Women’s Health Equity Initiative resources below!
|
|
|
The Initiative is just one part of SWHR's lupus work. Check out more resources like the Lupus Wellness Toolkit and "Closing the Loop for Lupus" webinar series below and on swhr.org. And join us on social media at #SWHRtalksLupus to celebrate Lupus Awareness Month all May long!
|
|
Are you living with lupus? Share your story with SWHR by visiting swhr.org/shareyourstory and you could help inform future wellness resources.
|
|
SWHR Presents Full Autoimmune Policy Series
An estimated 50 million Americans live with autoimmune diseases, but 80 percent of these individuals are women. SWHR's Autoimmune Policy program this spring explored the gaps in research, treatment, coverage, and care access for individuals living with autoimmune conditions and recommended policy opportunities to close them.
Check out all the resources from the series, from webinars and expert interviews to policy briefs and a policy agenda. Find more on social media at #SWHRtalksAutoimmune.
The Webinars
|
|
Are you living with an autoimmune disease? Share your story with SWHR by visiting swhr.org/shareyourstory and you could help inform future autoimmune policy.
|
|
SWHR Statement on Ruling in Alliance for Hippocratic Medicine et al v FDA et al
The Society for Women’s Health Research (SWHR)—the national thought leader in promoting research on biological sex differences in disease and improving women’s health through science, policy, and education—is deeply concerned by the decision of Judge Kacsmaryk to invalidate the U.S. Food and Drug Administration’s (FDA) 23-year-old approval of mifepristone. We are concerned that this ruling sets a harmful precedent for future treatments for women as well as for the potential of the courts to circumvent FDA’s authority, placing medical and science-based decision-making outside the purview of medical and public health professionals. Read the full statement.
SWHR Response to House’s Passage of the Limit, Save, Grow Act of 2023
On Wednesday, April 26, the U.S. House of Representatives passed the Limit, Save, Grow Act of 2023. The legislation would suspend the debt limit until March 31, 2024 (or until the debt reaches $1.5 trillion); return total discretionary spending to the fiscal year 2022 level in fiscal year 2024 (amounting to more than $130 billion in cuts) and cap annual growth at 1 percent from fiscal year 2025 through fiscal year 2033. SWHR is deeply concerned about what these cuts could mean for federal research and women’s health. SWHR signed onto an NDD United letter opposing this legislation. Read more.
|
|
|
|
SWHR is Hiring!
SWHR is hiring for a Science Programs Manager to support research, development, and execution work on the science team. Learn about the role here and apply today!
|
Have you read the SWHR 2022 Annual Report?
Through 2022, SWHR continued to encourage inclusion of women and underrepresented populations in research; advocate for greater women’s health research funding, and much more. Explore the 2022 SWHR Annual Report.
|
|
Know something SWHR should read? Reply to this email or tag us on social media at @SWHR!
|
|
Did someone forward you this email? Looking for more news on women's health research? |
|
|
|
|
|
|
|
